Amino Acid-Responsive Crohn's Disease: A Case Study [Retraction].
- Published in:
- Clinical & Experimental Gastroenterology, 2020, v. 13, p. 589, doi. 10.2147/CEG.S296322
- By:
- Publication type:
- Article
Works matching AU Hinz, Marty
Results: 55
1
2
Amino Acid-Responsive Crohn's Disease: A Case Study [Expression of Concern].
- Published in:
- Clinical & Experimental Gastroenterology, 2020, v. 13, p. 105, doi. 10.2147/ceg.s296322
- By:
- Publication type:
- Article
3
Amino acid-responsive Crohn's disease: a case study.
- Published in:
- Clinical & Experimental Gastroenterology, 2010, v. 3, p. 171, doi. 10.2147/CEG.S15340
- By:
- Publication type:
- Article
4
Validity of urinary monoamine assay sales under the "spot baseline urinary neurotransmitter testing marketing model".
- Published in:
- International Journal of Nephrology & Renovascular Disease, 2011, v. 4, p. 101, doi. 10.2147/IJNRD.S22783
- By:
- Publication type:
- Article
5
The Discrediting of the Monoamine Hypothesis [Retraction].
- Published in:
- International Journal of General Medicine, 2020, v. 13, p. 1547, doi. 10.2147/IJGM.S296329
- By:
- Publication type:
- Article
6
Relative Nutritional Deficiencies Associated with Centrally Acting Monoamines [Retraction].
- Published in:
- International Journal of General Medicine, 2020, v. 13, p. 1549, doi. 10.2147/IJGM.S296330
- By:
- Publication type:
- Article
7
Amino Acid Management of Parkinson's Disease: a Case Study [Retraction].
- Published in:
- International Journal of General Medicine, 2020, v. 13, p. 1545, doi. 10.2147/IJGM.S296324
- By:
- Publication type:
- Article
8
The Discrediting of the Monoamine Hypothesis [Expression of Concern].
- Published in:
- International Journal of General Medicine, 2020, v. 13, p. 141, doi. 10.2147/ijgm.s296329
- By:
- Publication type:
- Article
9
Relative Nutritional Deficiencies Associated with Centrally Acting Monoamines [Expression of Concern].
- Published in:
- International Journal of General Medicine, 2020, v. 13, p. 143, doi. 10.2147/ijgm.s296330
- By:
- Publication type:
- Article
10
Amino Acid Management of Parkinson's Disease: A Case Study [Expression of Concern].
- Published in:
- International Journal of General Medicine, 2020, v. 13, p. 145, doi. 10.2147/ijgm.s296324
- By:
- Publication type:
- Article
11
Relative nutritional deficiencies associated with centrally acting monoamines.
- Published in:
- International Journal of General Medicine, 2012, v. 5, p. 413, doi. 10.2147/IJGM.S31179
- By:
- Publication type:
- Article
12
The discrediting of the monoamine hypothesis.
- Published in:
- International Journal of General Medicine, 2012, v. 5, p. 135, doi. 10.2147/IJGM.S27824
- By:
- Publication type:
- Article
13
Amino acid management of Parkinson's disease: a case study.
- Published in:
- International Journal of General Medicine, 2011, v. 4, p. 165, doi. 10.2147/IJGM.S16621
- By:
- Publication type:
- Article
14
Parkinson's disease: carbidopa, nausea, and dyskinesia.
- Published in:
- Clinical Pharmacology, 2014, v. 6, p. 189, doi. 10.2147/CPAA.S72234
- By:
- Publication type:
- Article
15
Administration of supplemental L-tyrosine with phenelzine: a clinical literature review.
- Published in:
- Clinical Pharmacology, 2014, v. 6, p. 107, doi. 10.2147/CPAA.S67271
- By:
- Publication type:
- Article
16
The Parkinson's disease death rate: carbidopa and vitamin B6.
- Published in:
- Clinical Pharmacology, 2014, v. 6, p. 161, doi. 10.2147/CPAA.S70707
- By:
- Publication type:
- Article
17
Microperforation prolotherapy: a novel method for successful nonsurgical treatment of atraumatic spontaneous anterior sternoclavicular subluxation, with an illustrative case.
- Published in:
- Open Access Journal of Sports Medicine, 2011, v. 2, p. 47, doi. 10.2147/OAJSM.S20579
- By:
- Publication type:
- Article
18
Monoamine Depletion by Reuptake Inhibitors [Retraction].
- Published in:
- Drug, Healthcare & Patient Safety, 2020, v. 12, p. 269, doi. 10.2147/DHPS.S296327
- By:
- Publication type:
- Article
19
Management of L-Dopa Overdose in the Competitive Inhibition State [Retraction].
- Published in:
- Drug, Healthcare & Patient Safety, 2020, v. 12, p. 271, doi. 10.2147/DHPS.S296332
- By:
- Publication type:
- Article
20
Monoamine Depletion by Reuptake Inhibitors [Expression of Concern].
- Published in:
- Drug, Healthcare & Patient Safety, 2020, v. 12, p. 57, doi. 10.2147/dhps.s296327
- By:
- Publication type:
- Article
21
Management of L-Dopa Overdose in the Competitive Inhibition State [Expression of Concern].
- Published in:
- Drug, Healthcare & Patient Safety, 2020, v. 12, p. 59, doi. 10.2147/dhps.s296332
- By:
- Publication type:
- Article
22
Management of L-dopa overdose in the competitive inhibition state.
- Published in:
- Drug, Healthcare & Patient Safety, 2014, v. 6, p. 93, doi. 10.2147/DHPS.S67328
- By:
- Publication type:
- Article
23
Monoamine depletion by reuptake inhibitors.
- Published in:
- Drug, Healthcare & Patient Safety, 2011, v. 3, p. 69
- By:
- Publication type:
- Article
24
Parkinson's Disease: Carbidopa, Nausea, and Dyskinesia [Retraction].
- Published in:
- Clinical Pharmacology, 2021, v. 13, p. 43, doi. 10.2147/CPAA.S308259
- By:
- Publication type:
- Article
25
The Parkinson's Disease Death Rate: Carbidopa and Vitamin B6 [Retraction].
- Published in:
- Clinical Pharmacology, 2021, v. 13, p. 41, doi. 10.2147/CPAA.S308256
- By:
- Publication type:
- Article
26
Administration of Supplemental L-Tyrosine with Phenelzine: a Clinical Literature Review [Retraction].
- Published in:
- Clinical Pharmacology, 2021, v. 13, p. 39, doi. 10.2147/CPAA.S308255
- By:
- Publication type:
- Article
27
The Parkinson's Disease Death Rate: Carbidopa and Vitamin B6 [Expression of Concern].
- Published in:
- Clinical Pharmacology, 2020, v. 12, p. 43, doi. 10.2147/CPAA.S240231
- By:
- Publication type:
- Article
28
Parkinson's Disease: Carbidopa, Nausea, and Dyskinesia [Expression of Concern].
- Published in:
- Clinical Pharmacology, 2020, v. 12, p. 45, doi. 10.2147/CPAA.S240233
- By:
- Publication type:
- Article
29
Administration of Supplemental L-Tyrosine with Phenelzine: A Clinical Literature Review [Expression of Concern].
- Published in:
- Clinical Pharmacology, 2020, v. 12, p. 47, doi. 10.2147/CPAA.S240229
- By:
- Publication type:
- Article
30
Parkinson's Disease-Associated Melanin Steal [Retraction].
- Published in:
- Neuropsychiatric Disease & Treatment, 2021, v. 17, p. 733, doi. 10.2147/NDT.S308261
- By:
- Publication type:
- Article
31
5-HTP Efficacy and Contraindications [Retraction].
- Published in:
- Neuropsychiatric Disease & Treatment, 2021, v. 17, p. 731, doi. 10.2147/NDT.S308254
- By:
- Publication type:
- Article
32
Treatment of Attention Deficit Hyperactivity Disorder with Monoamine Amino Acid Precursors and Organic Cation Transporter Assay Interpretation [Retraction].
- Published in:
- Neuropsychiatric Disease & Treatment, 2020, v. 16, p. 3131, doi. 10.2147/NDT.S296323
- By:
- Publication type:
- Article
33
The Dual-Gate Lumen Model of Renal Monoamine Transport [Retraction].
- Published in:
- Neuropsychiatric Disease & Treatment, 2020, v. 16, p. 3133, doi. 10.2147/NDT.S296318
- By:
- Publication type:
- Article
34
Parkinson's Disease Managing Reversible Neurodegeneration [Retraction].
- Published in:
- Neuropsychiatric Disease & Treatment, 2020, v. 16, p. 3125, doi. 10.2147/NDT.S296333
- By:
- Publication type:
- Article
35
Both Stimulatory and Inhibitory Effects of Dietary 5-Hydroxytryptophan and Tyrosine are Found on Urinary Excretion of Serotonin and Dopamine in a Large Human Population [Retraction].
- Published in:
- Neuropsychiatric Disease & Treatment, 2020, v. 16, p. 3127, doi. 10.2147/NDT.S296314
- By:
- Publication type:
- Article
36
APRESS: Apical Regulatory Super System, Serotonin, and Dopamine Interaction [Retraction].
- Published in:
- Neuropsychiatric Disease & Treatment, 2020, v. 16, p. 3123, doi. 10.2147/NDT.S296326
- By:
- Publication type:
- Article
37
A Pilot Study Differentiating Recurrent Major Depression from Bipolar Disorder Cycling on the Depressive Pole [Retraction].
- Published in:
- Neuropsychiatric Disease & Treatment, 2020, v. 16, p. 3129, doi. 10.2147/NDT.S296320
- By:
- Publication type:
- Article
38
Treatment of Attention Deficit Hyperactivity Disorder with Monoamine Amino Acid Precursors and Organic Cation Transporter Assay Interpretation [Expression of Concern].
- Published in:
- Neuropsychiatric Disease & Treatment, 2020, v. 16, p. 1067, doi. 10.2147/ndt.s296323
- By:
- Publication type:
- Article
39
The Dual-Gate Lumen Model of Renal Monoamine Transport [Expression of Concern].
- Published in:
- Neuropsychiatric Disease & Treatment, 2020, v. 16, p. 1085, doi. 10.2147/ndt.s296318
- By:
- Publication type:
- Article
40
Parkinson's Disease-Associated Melanin Steal [Expression of Concern].
- Published in:
- Neuropsychiatric Disease & Treatment, 2020, v. 16, p. 1063, doi. 10.2147/NDT.S240234
- By:
- Publication type:
- Article
41
Parkinson's Disease Managing Reversible Neurodegeneration [Expression of Concern].
- Published in:
- Neuropsychiatric Disease & Treatment, 2020, v. 16, p. 1061, doi. 10.2147/ndt.s296333
- By:
- Publication type:
- Article
42
Both Stimulatory and Inhibitory Effects of Dietary 5-Hydroxytryptophan and Tyrosine are Found on Urinary Excretion of Serotonin and Dopamine in a Large Human Population [Expression of Concern].
- Published in:
- Neuropsychiatric Disease & Treatment, 2020, v. 16, p. 1069, doi. 10.2147/ndt.s296314
- By:
- Publication type:
- Article
43
APRESS: Apical Regulatory Super System, Serotonin and Dopamine Interaction [Expression of Concern].
- Published in:
- Neuropsychiatric Disease & Treatment, 2020, v. 16, p. 1071, doi. 10.2147/ndt.s296326
- By:
- Publication type:
- Article
44
A Pilot Study Differentiating Recurrent Major Depression from Bipolar Disorder Cycling on the Depressive Pole [Expression of Concern].
- Published in:
- Neuropsychiatric Disease & Treatment, 2020, v. 16, p. 1065, doi. 10.2147/ndt.s296320
- By:
- Publication type:
- Article
45
5-HTP Efficacy and Contraindications [Expression of Concern].
- Published in:
- Neuropsychiatric Disease & Treatment, 2020, v. 16, p. 1059, doi. 10.2147/NDT.S240228
- By:
- Publication type:
- Article
46
Parkinson's disease managing reversible neurodegeneration.
- Published in:
- Neuropsychiatric Disease & Treatment, 2016, v. 12, p. 763, doi. 10.2147/NDT.S98367
- By:
- Publication type:
- Article
47
Parkinson's disease-associated melanin steal.
- Published in:
- Neuropsychiatric Disease & Treatment, 2014, v. 10, p. 2331, doi. 10.2147/NDT.S74952
- By:
- Publication type:
- Article
48
5-HTP efficacy and contraindications.
- Published in:
- Neuropsychiatric Disease & Treatment, 2012, v. 8, p. 323, doi. 10.2147/NDT.S33259
- By:
- Publication type:
- Article
49
Neurotransmitter Testing of the Urine: a Comprehensive Analysis [Retraction].
- Published in:
- Research & Reports in Urology, 2020, v. 12, p. 661, doi. 10.2147/RRU.S296319
- By:
- Publication type:
- Article
50
Urinary Neurotransmitter Testing: Considerations of Spot Baseline Norepinephrine and Epinephrine [Retraction].
- Published in:
- Research & Reports in Urology, 2020, v. 12, p. 659, doi. 10.2147/RRU.S296325
- By:
- Publication type:
- Article